These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7723497)

  • 41. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease.
    Beohar N; Damaraju S; Prather A; Yu QT; Raizner A; Kleiman NS; Roberts R; Marian AJ
    J Investig Med; 1995 Jun; 43(3):275-80. PubMed ID: 7614074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects.
    Pan Y; Wang F; Qiu Q; Ding R; Zhao B; Zhou H
    PLoS One; 2013; 8(12):e83415. PubMed ID: 24349507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias.
    Agema WR; Jukema JW; Zwinderman AH; van der Wall EE
    Am Heart J; 2002 Nov; 144(5):760-8. PubMed ID: 12422143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
    Desmet W; Vrolix M; De Scheerder I; Van Lierde J; Willems JL; Piessens J
    Circulation; 1994 Jan; 89(1):385-92. PubMed ID: 8281674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
    Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
    Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of angiotensin-I-converting-enzyme insertion/deletion gene polymorphism on perioperative hemodynamics after coronary bypass graft surgery.
    Popov AF; Hinz J; Liakopoulos OJ; Schmitto JD; Seipelt R; Quintel M; Schoendube FA
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):255-60. PubMed ID: 18431347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
    Schmitz HJ; Erbel R; Meyer J; von Essen R
    Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty.
    Hamon M; Amant C; Bauters C; Lablanche JM; Bertrand M; Amouyel P
    Am J Cardiol; 1996 Sep; 78(6):679-81. PubMed ID: 8831406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
    Ribichini F; Wijns W; Ferrero V; Matullo G; Camilla T; Feola M; Guarrera S; Vado A; Piazza A; Uslenghi E
    Am J Cardiol; 2003 Jan; 91(2):154-8. PubMed ID: 12521626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insertion/deletion polymorphism of angiotensin-converting enzyme gene--risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina).
    Terzić R; Letonja M; Terzić I; Sehić A; Merić M; Teran N
    Coll Antropol; 2003 Dec; 27(2):537-40. PubMed ID: 14746140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation.
    Canosi U; Angelica Merlini P; Bernardi F; Repetto A; Bramucci E; Ferrario M; Angoli L; Gnecchi M; Ferraresi P; Marchetti G; Tavazzi L; Ardissino D
    Thromb Haemost; 2004 Apr; 91(4):795-800. PubMed ID: 15045142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery.
    Völzke H; Engel J; Kleine V; Schwahn C; Dahm JB; Eckel L; Rettig R
    Chest; 2002 Jul; 122(1):31-6. PubMed ID: 12114335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.
    Francis SE; Camp NJ; Burton AJ; Dewberry RM; Gunn J; Stephens-Lloyd A; Cumberland DC; Gershlick A; Crossman DC
    Heart; 2001 Sep; 86(3):336-40. PubMed ID: 11514491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.
    Arbustini E; Grasso M; Fasani R; Klersy C; Diegoli M; Porcu E; Banchieri N; Fortina P; Danesino C; Specchia G
    Br Heart J; 1995 Dec; 74(6):584-91. PubMed ID: 8541160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris.
    Kasi JC; Zhang Y; Calvino R; Vazquez-Rodriguez JM; Castro-Beiras A; Jeffery S; Carter N
    Am J Cardiol; 1996 Apr; 77(10):875-7. PubMed ID: 8623745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic markers of restenosis after coronary angioplasty and after stent implantation.
    Petrovic D; Peterlin B
    Med Sci Monit; 2005 Apr; 11(4):RA127-35. PubMed ID: 15795709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The II genotype of the angiotensin-converting enzyme gene delays the onset of acute coronary syndromes.
    Iwai N; Tamaki S; Ohmichi N; Kinoshita M
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1730-3. PubMed ID: 9327770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.